You have 9 free searches left this month | for more free features.

Condition

Healthy Subjects (1)

Moderate to Severe Atopic Dermatitis (1)

Overall Status

Completed (1)

Not yet recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Beijing InnoCare Pharma Tech Co., Ltd. (2)

Collaborator

Intervention

icp-332 (2)

icp-332 placebo (1)

placebo (1)

Study Documents

Intervention Type

drug (2)

other (1)

Funder Type

Industry (2)

Study Type

Interventional (2)

icp-332

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Healthy Subjects Trial in Jinan (ICP-332, Placebo)

Completed

Healthy Subjects

ICP-332
Placebo

Jinan, China

Jinan Central Hospital

Aug 5, 2022

Moderate to Severe Atopic Dermatitis Trial in China (ICP-332, ICP-332 Placebo)

Not yet recruiting

Moderate to Severe Atopic Dermatitis

ICP-332
ICP-332 Placebo

Beijing, Beijing, China
+21 more

Jan 18, 2023